ORAGENICS, INC. Amortization of Debt Issuance Costs and Discounts
ORAGENICS, INC. (OGEN) reported Amortization of Debt Issuance Costs and Discounts of $771.44 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-13
- ORAGENICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $0.00.
- ORAGENICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $0.00.
- ORAGENICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-06-30 was $578.58K.
- ORAGENICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-03-31 was $192.86K.
- ORAGENICS, INC. amortization of debt issuance costs and discounts for fiscal 2025 was $771.44K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $578.58K derived: sum of 3 quarters · filed 2026-08-13 | $771.44K 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $578.58K derived: sum of 2 quarters · filed 2026-08-13 | $771.44K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $578.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $771.44K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $192.86K 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |